Medical Devices Seed Investors & VC Firms

1155 firms in this list, with a median first check of $500K. 233 of them lead rounds. Generated from verified public data and updated continuously.

Fund	HQ	Invests	Stage	Check	CRM
W Health Ventures Gp Llc 15 people · Leads rounds	Boston	US	Pre-Seed–Series A	$1M – $5M	+ Add to CRM
Invivo Capital Partners 11 people	Barcelona	ES	Pre-Seed–Series A	$2.2M – $4.3M	+ Add to CRM
Medical Excellence Capital 17 people · Follows rounds	New York	US	Pre-Seed–Series B	—	+ Add to CRM
Alix Ventures 19 people · Leads rounds	San Francisco	US	Pre-Seed–Series A	$100K – $500K	+ Add to CRM
AME Cloud Ventures 10 people · Leads rounds	Palo Alto	US	Seed–Late Stage	$1M – $10M	+ Add to CRM
RDiscovery 19 people · Leads rounds	Tokyo	JP	Pre-Seed–Series A	—	+ Add to CRM
V-Bio Ventures 13 people	Ghent	BE	Seed–Growth	$270K – $2.2M	+ Add to CRM
Walking Ventures 4 people · Leads rounds	London	GB	Pre-Seed–Series A	$650K – $1.3M	+ Add to CRM
Oxford Technology Management 6 people · Leads rounds	Oxford	GB	Pre-Seed–Series A	$200K – $400K	+ Add to CRM
Shackleton Ventures Ltd. 6 people	London	GB	Seed–Series A	$952.5K – $25.4M	+ Add to CRM
Bioqube Ventures 19 people	Brussels	BE	Pre-Seed–Late Stage	$108K – $6.5M	+ Add to CRM
WELL Ventures 16 people	Vancouver	CA	Seed–Growth	—	+ Add to CRM
SCI Ventures 18 people	London	GB	Seed–Series B	—	+ Add to CRM
Sonder Capital 15 people	San Carlos	US	Pre-Seed–Late Stage	—	+ Add to CRM
SyndicateRoom 15 people · Follows rounds	Cambridge	GB	Pre-Seed–Series A	—	+ Add to CRM
LYFE Capital 17 people · Follows rounds	Menlo Park	US	Seed–Late Stage	—	+ Add to CRM
New Science Ventures 7 people · Leads rounds	Greenwich	US	Seed–Late Stage	$2M – $8M	+ Add to CRM
Big Red Ventures 18 people · Follows rounds	Ithaca	US	Pre-Seed–Series A	$25K	+ Add to CRM
Brightlands Venture Partners 15 people · Follows rounds	Geleen	NL	Seed–Series B	$540K – $2.2M	+ Add to CRM
CTI Life Sciences Fund L.P. 9 people · Follows rounds	Montréal	CA	Seed–Late Stage	—	+ Add to CRM
Puhua Capital Follows rounds	Hangzhou	CN	Pre-Seed–Late Stage	$1.4M – $112M	+ Add to CRM
White Fund 15 people	Liège	BE	Seed–Series B	$2.2M – $5.4M	+ Add to CRM
Cowin Capital Group 11 people	Shenzhen	CN	Seed–Late Stage	$1.4M – $50M	+ Add to CRM
Pathway to Cures 20 people	New York	US	Seed–Series A	—	+ Add to CRM